Call us anytime 905-948-9969
Opening Time Mon - Fri: 9AM - 6PM

ColonSentry ® is a minimally invasive, blood-based risk assessment test for colorectal cancer. The test is used to increase patient compliance with colonoscopy. Many physicians have inquired about the incidence of non-malignant lesions found in patients after colonoscopy prompted by an increased risk score on the ColonSentry test. Here we report on the colonoscopy results of five patients with increased ColonSentry risk scores. Of those five patients, three were determined to have polyps, one of which was pre-malignant.

Blood-based Dynamic Genomic Signature for Obsessive-Compulsive Disorder
Differential Regulation of Peripheral Leukocyte Genes in Patients With Active Crohn's Disease and Crohn's Disease in Remission
Leave a comment

Please login or register to review